Skip to main content

Advertisement

SpringerLink
Log in

Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients

  • Letter to the Editor
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Niedzwiecki S, Stepien T, Kuzdak K et al (2008) Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients. Langenbecks Arch Surg 393:275–280 doi:10.1007/s00423-007-0251-9

    Article  PubMed  Google Scholar 

  2. Kaminska J, Kowalska MM, Nowacki MP, Chwalinski MG, Rysinska A, Fuksiewicz M (2000) CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients. Pathol Oncol Res 6:38–41

    Article  PubMed  CAS  Google Scholar 

  3. Ito H, Miki C (1999) Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol 34:1139–1143 doi:10.1080/003655299750024959

    Article  PubMed  CAS  Google Scholar 

  4. Fuksiewicz M, Kaminska J, Kotowicz B, Kowalska M, Rubach M, Pienkowski T (2006) Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients. Clin Chem Lab Med 44:1092–1097 doi:10.1515/CCLM.2006.192

    Article  PubMed  CAS  Google Scholar 

  5. Fujiwaki R, Hata T, Miyazaki K, Kawamura T, Inada K (1997) Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers. Br J Obstet Gynaecol 104:1407–1408

    PubMed  CAS  Google Scholar 

  6. Barak V, Nisman B, Polliack A, Vannier E, Dinarello CA (1998) Correlation of serum levels of interleukin-1 family members with disease activity and response to treatment in hairy cell leukemia. Eur Cytokine Netw 9:33–39

    PubMed  CAS  Google Scholar 

  7. Szczesny TJ, Slotwinski R, Stankiewicz A, Szczygiel B, Zaleska M, Kopacz M (2007) Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery. Eur J Cardiothorac Surg 31:719–724 doi:10.1016/j.ejcts.2007.01.027

    Article  PubMed  Google Scholar 

  8. Slotwinski R, Olszewski WL, Slotkowski M et al (2007) Can the interleukin-1 receptor antagonist (IL-1ra) be a marker of anti-inflammatory response to enteral immunonutrition in malnourished patients after pancreaticoduodenectomy? JOP 8:759–769

    PubMed  Google Scholar 

  9. Andreassen BU, Paerregaard A, Michaelsen KF, Andersen J, Heilmann CJ, Muller K (2008) Nutrition, anthropometry, gastrointestinal dysfunction, and circulating levels of tumour necrosis factor alpha receptor I and interleukin-1 receptor antagonist in children during stem cell transplantation. Pediatr Transplant (in press)

Download references

Author information

Authors and Affiliations

  1. Chicago, IL, 60195, USA

    Shailendra Kapoor

Authors
  1. Shailendra Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shailendra Kapoor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapoor, S. Clinical utility of serum Interleukin-1 receptor antagonist levels as a diagnostic and prognostic assay in surgical patients. Langenbecks Arch Surg 394, 401–402 (2009). https://doi.org/10.1007/s00423-008-0422-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-008-0422-3

Keywords

Search

Navigation